-
These hospitals were named for collecting reports, purchasing and other issues
Time of Update: 2022-10-19
In the four states and cities with low completion rates, 125 medical institutions failed to complete the agreed procurement volume, of which 73 medical institutions actually purchased 0.
-
The number of people vaccinated with the third dose of the new crown vaccine in Japan accounts for 65.7% of the country's total population
Time of Update: 2022-10-19
According to the Japan Broadcasting Association TV, the latest data released by the Japanese government on the 17th showed that the number of people who completed the third dose of the new crown vaccine in Japan was 82755821, accounting for 65.
-
The pharmaceutical and biological sector has risen sharply, and 8 related ETFs have risen and stopped!
Time of Update: 2022-10-19
For aftermarket opportunities, the industry also said that it can be tapped, focusing on potential main lines including IVD and high-value consumables that suppress valuations, investment-related medical equipment, innovative drugs, etc.
-
Launch the performance assessment of secondary and tertiary public hospitals in 2022
Time of Update: 2022-10-19
Health Commission of all provinces, autonomous regions, municipalities directly under the Central Government and the Xinjiang Production and Construction Corps: In order to implement the Opinions of
-
327 exclusive proprietary Chinese medicines sold for medical insurance exceeded 100 million, and Tasly won the championship!
Time of Update: 2022-10-19
In 2022, the countdown to the adjustment of the medical insurance catalogue has begun, and the 14 exclusive proprietary Chinese medicines that have passed the formal review are expected to join a new
-
Hubei: Continue to optimize medical insurance government services Continuously improve the level of convenient services for the people
Time of Update: 2022-10-19
Up to now, we have realized the "cross-province handling" of 7 high-frequency service items, including medical insurance electronic voucher application, insurance information change, urban and rural residents medical insurance enrollment registration, basic medical insurance relationship transfer and continuation, long-distance medical settlement filing, inter-provincial direct settlement of outpatient expenses, and basic information change of medical insurance designated hospitals.
-
Director of the US Centers for Disease Control and Prevention: The United States may usher in a severe influenza season this year
Time of Update: 2022-10-19
On October 14, local time, Rochelle Walensky, director of the US Centers for Disease Control and Prevention (CDC), said that the United States may usher in a severe flu season this year.
-
The bispecific antibody market is expanding rapidly, and the domestic scale will exceed 10 billion yuan in 2030
Time of Update: 2022-10-19
On the whole, with the establishment of relatively mature bispecific antibody technology platforms by domestic pharmaceutical companies in recent years, local bispecific antibody drugs have taken advantage of the momentum and are entering a stage of rapid development.
-
Driven by a number of favorable policies, individual stocks in the pharmaceutical sector have frequently risen and stopped
Time of Update: 2022-10-19
For example, on the evening of October 17, Bede Pharma issued an announcement that it is expected that the company's operating income in the first three quarters will increase by 38% year-on-year to 589 million yuan, and the non-net profit will increase by 46.
-
"A threesome must have a dry eye"? Eye health starts with the eye barrier
Time of Update: 2022-10-19
Scientific prevention and treatment of dry eye disease starts with paying attention to the health of the eye barrier In fact, People's Daily Health launched a survey on eye health in early September, which triggered a discussion on the topic of "70% of netizens losing the freedom to use their eyes".
-
The seventh batch of national procurement continues to land: Hebei, Yunnan, Henan and Hainan
Time of Update: 2022-10-19
5 billion yuan per year 。 At present, each province has successively issued notices on the implementation of the seventh batch of national procurement, which is summarized as follows: Yunnan: 3 products with defective drugs are purchased with quantity, and the one with the lowest quotation is selected On October 11, Yunnan Province issued the "Announcement on the Seventh Batch of Centralized Procurement of Some Drugs with Defective Specifications in Yunnan Province", which made hepatanol injection (50ml: 18.
-
WHO: More than 621.79 million confirmed cases of new coronary pneumonia worldwide
Time of Update: 2022-10-19
According to WHO's latest real-time statistics, as of 17:49 CET on October 17 (23:49 Beijing time on October 17), the cumulative number of confirmed cases of new coronary pneumonia in the world is 62
-
Food and Drug Administration: Temporarily extend the time limit for supplementary information for drug registration applications
Time of Update: 2022-10-19
js?cdnversion='+~(-new Date()/36e5)]; In order to thoroughly implement the decision-making and deployment of the Party Central Committee and the State Council on doing a good job in the "six stability" work and implementing the "six guarantees" task, support drug research and development, and promote the development of the pharmaceutical industry, it is decided to temporarily extend the time limit for supplementary information for drug registration applications, which is hereby announced as follows: 1.
-
Technology iteration accelerates Competition in the intracardiac ultrasound track intensifies
Time of Update: 2022-10-19
Intracardiac ultrasound (ICE) is an emerging echocardiographic diagnostic technique that emits and receives high-frequency ultrasound signals by placing a catheter equipped with a miniature ultrasound transducer probe inside the heart chamber through a vascular pathway to achieve real-time imaging of the anatomy of the heart.
-
Chia Tai sky is open and hanging! 61 Class 1 new drugs and 7 blockbuster monoclonal antibody screens
Time of Update: 2022-10-19
js?cdnversion='+~(-new Date()/36e5)]; Recently, the R&D pipeline of CP Tianqing Pharmaceutical welcomes new progress: class 1 new drug TQB2102 is declared for clinical for the first time, the introduction of heavy NASH new drugs, and class 4 generic drugs are reported for production of bicarutamide tablets.
-
Investment opportunities in the pharmaceutical sector in the fourth quarter: focus on three major directions
Time of Update: 2022-10-19
【Pharmaceutical Network Market Analysis】Last week, the pharmaceutical biotechnology sector rose significantly, and the rebound trend appeared. According to Dongguan Securities Research Report, from Oc
-
Jiangxi and other 22 provinces liver function biochemical reagents collection The latest news flowed out
Time of Update: 2022-10-19
js?cdnversion='+~(-new Date()/36e5)]; According to industry insiders, the collection and procurement plan of liver function biochemical reagents in 22 provinces such as Jiangxi is currently undergoing internal solicitation of opinions, and relevant points have flowed out.
-
Behind the 5-minute drop in patient waiting time: the big work of big data in hospitals
Time of Update: 2022-10-14
Recently, the reporter learned in the Shanxi Provincial Health Commission to promote medical reform "media to the grassroots" activity that Shen Li, director of the outpatient department of Shanxi Provincial People's Hospital, and the team took the details of the above management as the starting point to continuously improve the system, so that the patient's waiting time was reduced from 17 minutes to 12 minutes, the doctor's on-time consultation rate increased to 95%, the suspension rate dropped from 14.
-
The 100 billion market is reshuffled, and Yangzijiang grabs food with 4 new drugs of 1 class
Time of Update: 2022-10-14
Recently, the CDE official website news, Yangtze River Pharmaceutical Group wholly-owned subsidiary Shanghai Haiyan Pharmaceutical Technology Co. , Ltd. Class 1 new drug YZJ-4729 tartrate injection w
-
The State Food and Drug Administration issued the Catalogue of Generic Drug Reference Preparations (59th Batch)
Time of Update: 2022-10-14
01% Nisshin Sakura Corporation No original drugs have been imported Listed in Japan Clarithromycin lactamate for injection Powder for Concentrate for Solution for Infusion Clarithromycin/ Klaricid 500mg Mylan Products Limited Listed in the UK Lidocaine spray Lidocaine Spray/Xylocaine 10mg Spray 10 mg/spray, 50 ml/bottle Aspen Pharma Trading Limited No original drugs have been imported Listed in the UK Polyethylene glycol sodium potassium powder / compound polyethylene glycol (3350) electrolyte dispersion Movicol Paediatric Chocolate Flavour 6.
![9-[3-Chloro-5-(phenanthren-9-yl)phenyl]phenanthrene / 1369431-34-4](https://file.echemi.com/fileManage/upload/goodpicture/20241028/9-3-chloro-5-phenanthren-9-ylphenylphenanthrene-1369431-34-4_b20241028151130118.jpg)
